AP

Anoop Patel

Active Director Director DIN 08644344
DIN 08644344 First appointment Dec 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value •••• Premium profile

About Anoop Patel

Data last updated:

Anoop Patel is a Director at Befit Pharma Private Limited (since 2019). The company operates in Healthcare. Befit Pharma Private Limited reported revenue of ₹28.3 Lakh (FY 2025).

DIN 08644344
Primary Designation Director
Industry Healthcare
First Appointment 19 Dec 2019
Oldest Company Age 6 yrs
Largest company Befit Pharma Private Limited · ₹28.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Befit Pharma Private Limited U33110DL2019PTC359028
Director19 Dec 20192019₹28.3 Lakh (FY 2025)Active

Board colleagues of Anoop Patel

NameDINCompanyDesignation
Sandeep08644343Befit Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Befit Pharma Private Limited
Premium access

Shareholding and investment profile for Anoop Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anoop Patel

Anoop Patel currently holds 1 directorship: Befit Pharma Private Limited (Director, since 19 Dec 2019, revenue ₹28.3 Lakh (FY 2025)).

Anoop Patel was first appointed on 19 Dec 2019 as Director at Befit Pharma Private Limited.

The current boards of Anoop Patel's companies include Sandeep (Befit Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available